Literature DB >> 33014398

Letter to the Editor regarding clinical debate concerning treatment of pediatric LGG by Cooney et al.

Matthias A Karajannis1, Mark M Souweidane2, Ira J Dunkel1.   

Abstract

Year:  2020        PMID: 33014398      PMCID: PMC7516102          DOI: 10.1093/nop/npaa019

Source DB:  PubMed          Journal:  Neurooncol Pract        ISSN: 2054-2577


× No keyword cloud information.
  5 in total

1.  Carboplatin for the treatment of children with newly diagnosed optic chiasm gliomas: a phase II study.

Authors:  V M Aquino; D W Fort; B A Kamen
Journal:  J Neurooncol       Date:  1999-02       Impact factor: 4.130

2.  Single agent carboplatin for pediatric low-grade glioma: A retrospective analysis shows equivalent efficacy to multiagent chemotherapy.

Authors:  Andrew J Dodgshun; Wirginia J Maixner; John A Heath; Michael J Sullivan; Jordan R Hansford
Journal:  Int J Cancer       Date:  2015-08-13       Impact factor: 7.396

3.  Phase II study of carboplatin in children with progressive low-grade gliomas.

Authors:  Sridharan Gururangan; Christina M Cavazos; David Ashley; James E Herndon; Carol S Bruggers; Albert Moghrabi; Deborah L Scarcella; Melody Watral; Sandra Tourt-Uhlig; David Reardon; Henry S Friedman
Journal:  J Clin Oncol       Date:  2002-07-01       Impact factor: 44.544

4.  Childhood Optic Nerve Glioma: Vision Loss Due to Biopsy.

Authors:  Karen E Revere; William R Katowitz; James A Katowitz; Lucy Rorke-Adams; Michael J Fisher; Grant T Liu
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2017 May/Jun       Impact factor: 1.746

Review 5.  Neuro-Oncology Practice Clinical Debate: targeted therapy vs conventional chemotherapy in pediatric low-grade glioma.

Authors:  Tabitha Cooney; Kee Kiat Yeo; Cassie Kline; Michael Prados; Daphne Haas-Kogan; Susan Chi; Sabine Mueller
Journal:  Neurooncol Pract       Date:  2019-08-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.